BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Europe

Menarini Group Partners with Insilico Medicine on AI-Discovered Oncology Asset in $550M Licensing Deal

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, si...

January 13, 2025 | News

Biofidelity and CellCarta Forge Partnership to Advance Lung Cancer Genomic Testing in Clinical Trials

Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmac...

January 10, 2025 | News

UK Biobank Proteomics Project Partners with Thermo Fisher to Map Disease-Linked Proteins for Precision Medicine

UK Biobank Pharma Proteomics Project aims to create a comprehensive map of disease-associated protein levels in the human body to advance biomarker discove...

January 10, 2025 | News

Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development

In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, German...

January 10, 2025 | News

ProBioGen Expands Protein and Virus Manufacturing Capabilities at Berlin Headquarters

ProBioGen announces the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an addi...

January 09, 2025 | News

Leica Biosystems Partners with Indica Labs to Transform AI-Driven Digital Pathology

Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine par...

January 09, 2025 | News

Glooko and Hedia Launch Interoperable Solution for Advanced Diabetes Management in the UK

Glooko, Inc. and Hedia, announced the launch of their interoperable solution, which combines connected care, remote patient monitoring, and digital th...

January 09, 2025 | News

DIOSynVax Introduces New Influenza Vaccine Portfolio and Advisory Board to Tackle Global Pandemic Threats

DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated ...

January 09, 2025 | News

Genomics England Partners with QIAGEN to Deliver Pioneering Whole-Genome Sequencing Study for Newborns

Genomics England select QIAGEN’s Clinical Knowledge Base to power first-of-its-kind whole-genome sequencing study for newborns National stud...

January 08, 2025 | News

GORTEC's Phase 3 Trial Shows Nivolumab Improves Disease-Free Survival in High-Risk Head and Neck Cancer Patients

GORTEC, known as Head and Neck Radiation Oncology Group, announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, ...

January 08, 2025 | News

Norgine Submits Marketing Authorisation Application to EMA for Eflornithine in High-Risk Neuroblastoma

Norgine announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk ne...

January 07, 2025 | News

Chime Biologics and Mabgeek Achieve Major Milestone with PPQ Completion for MG-K10 Antibody

Process Performance Qualification (PPQ) validates robust manufacturing standards and is crucial for regulatory compliance Marks a key step forward for t...

January 06, 2025 | News

European Commission Approves Amivantamab Plus Lazertinib for First-Line Treatment of EGFR-Mutated NSCLC

Janssen-Cilag International NV, a Johnson & Johnson company,announced the European Commission (EC) approval for a Type II variation indication extensio...

January 03, 2025 | News

Sensorion Completes Enrollment for First Cohort in Audiogene Phase 1/2 Gene Therapy Trial

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to re...

January 01, 2025 | News

Stay Connected